Prevalence of Telogen Effluvium Hair Loss in COVID-19 Patients and Its Relationship with Disease Severity

May 2022 in “ Journal of medicine and life ”

Shahram Seyfi, Robabeh Alijanpour, Zeinab Aryanian, Khadijeh Ezoji, Mahdi Mahmoudi

telogen effluvium hair loss COVID-19 stress medications positive COVID-19 test TE

TLDR COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

This cross-sectional study investigated the prevalence of telogen effluvium (TE), a type of hair loss, in 198 COVID-19 patients at Rohani hospital of Babol Medical University Of Sciences. The study found that 48 patients experienced hair loss, suggesting TE could be a consequence of the COVID-19 pandemic, potentially due to the stress and medications related to the disease. There was no correlation found between hair loss and the patients' age or sex, but there was a significant correlation between a positive COVID-19 test and hair loss. The study emphasizes that physicians should be aware of the potential for delayed TE in COVID-19 patients and highlights the need for further research to understand the mechanisms behind TE in the context of COVID-19.

View this study on medandlife.org →

Discuss this study in the Community →

Cited in this study

9 / 9 results

research A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation

25 citations , December 2021 in “Journal of Medical Virology”

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

research Efficacy of QR678 Neo Hair Growth Factor Formulation for the Treatment of Hair Loss in COVID-19-Induced Persistent Telogen Effluvium: A Prospective, Clinical, Single-Blind Study

5 citations , December 2021 in “Journal of Cosmetic Dermatology”

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

research COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium

25 citations , August 2021 in “Irish Journal of Medical Science (1971 -)”

COVID-19 infection can significantly cause temporary hair loss.

research Pathobiology Questions Raised by Telogen Effluvium and Trichodynia in COVID-19 Patients

18 citations , May 2021 in “Experimental Dermatology”

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

research Telogen Effluvium Associated with COVID-19 Infection

44 citations , January 2021 in “Dermatologic Therapy”

COVID-19 may cause hair loss due to infection stress or treatments.

research Cutaneous Manifestations and Considerations in COVID-19 Pandemic: A Systematic Review

101 citations , August 2020 in “Dermatologic therapy”

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

research Management of Telogen Effluvium During the COVID-19 Emergency: Psychological Implications

31 citations , June 2020 in “Dermatologic Therapy”

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

research Telogen Effluvium: A Review of the Literature

40 citations , May 2020 in “Cureus”

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

research Telogen Effluvium: A Review of Acute and Chronic Forms

67 citations , January 2013 in “Indian Journal of Dermatology, Venereology and Leprology”

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.